Authors


Ericka L. Adler

Latest:

E-mailing With Patients: Think Before You ‘Send’

When it comes to e-mail, I typically warn my [physician] clients of the following.


Erik R. Vanderlip, MD, MPH

Latest:

Depression and Diabetes: Improving Outcomes Through Collaborative Care

Depression and diabetes can prey on the shortcomings of our health care system, such as fragmented, episodic care and poor continuity. Coordinating care can be fraught with difficulties, but it is the goal of many current efforts in health care reform.


Erika L. Clark, MA

Latest:

Can Your Older Patient Drive Safely?

Medical professionals may be reluctant to initiate a discussion about driving with older patients in anticipation of a negative impact on the physician-patient relationship.


Erika Paradiso, MD

Latest:

Mood Stabilizers and Novel Antipsychotics in the Treatment of Borderline Personality Disorder

This article focuses on data concerning the efficacy of mood stabilizers in the treatment of BPD.


Erin B. Cooper, PhD

Latest:

Does Flibanserin Have a Future?

Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.


Erin Carlton, MS

Latest:

Inflammation, Psychosis, and the Brain

When the solution to a clinical or scientific puzzle eludes us for more than a century, as with schizophrenia, we need new methods to examine the pathology. If we want to make an impact on the disease we must shift research paradigms and focus on the early detection, early intervention, and new avenues of treatment that address different symptoms of schizophrenia.


Erin E. Hayes, MSIV

Latest:

Synthetic Cathinones: Signs, Symptoms, and Treatment

Sometimes viewed as “legal cocaine,” the over-the-counter status of synthetic cathinones (aka bath salts) gives the illusion that they are safe. In fact, they are highly toxic.


Erin E. Michalak, PhD

Latest:

Quality of Life in Patients With Bipolar Disorder: Defining and Measuring Goals

A complex and heterogeneous condition characterized by a variety of symptoms and marked variability in disease course, bipolar disorder is marked by episodes of depression, hypomania, mania, or psychosis and,patients can experience a mixture of emotional states.


Erin K. Kastenschmidt, MD

Latest:

Evolution of Mental Health Disorders: An Alternative Perspective

In Angst: Origins of Anxiety and Depression, Dr Jeffrey Kahn offers an alternative perspective on the evolution of common mental health disorders by considering the adaptive nature of symptoms that modern clinicians deem pathological.


Erin L. Belfort, MD

Latest:

The Double-Edged Sword of Social Media: Exploring the Complex Relationships Between Social Media Use and Youth Mental Health

Youth today have a relatively nuanced and mixed experience with social media. How can you best navigate this relationship as a mental health clinician?


Erin Walling, MSIV

Latest:

Inflammation, Immune Function, and Schizophrenia: An Overview

Current research investigates new pathophysiologic mechanisms and lays the groundwork for redefining schizophrenia based on distinct medical subclasses-which may lead to more targeted and effective treatments. Details here.


Erminia Scarcella, MD

Latest:

Symposium on Psychology and National Security at the Italian Embassy

The Embassy of Italy in Washington, DC recently hosted the first of 2 workshops on “Leaders and Terrorists: Psychological Perspectives on National Security.”


Ernst-wilhelm Radue, MD

Latest:

Multiple Sclerosis: MRI in Diagnosis, Management, and Monitoring

MRI has provided important insights into the pathophysiology of multiple sclerosis (MS).1 However, conventional MRI scans furnish only gross estimates of the nature and extent of tissue damage associated with MS,2 and the data correlate poorly with measures of concurrent disability in patients.


Esther Deblinger, PhD

Latest:

Trauma-Focused Cognitive-Behavioral Therapy for Sexually Abused Children

Cognitive-behavioral therapy can be tailored for use with children who have experienced sexual abuse in order to relieve symptoms of PTSD.


Ethan O. Bryson, MD

Latest:

Ketamine Anesthesia for Electroconvulsive Therapy

The authors review the clinical use of ketamine as the anesthetic induction agent in ECT and discuss the evidence that it augments antidepressant response and reduces cognitive adverse effects.


Ethel Spector Person, MD

Latest:

How To Work Through Erotic Transference

Erotic transference can be one of the most difficult issues to work through in psychotherapy. What is the history of the understanding of erotic transference, and what factors may play into its emergence in therapy?


Eugene V. Beresin, MD

Latest:

Children and Video Games: How Much Do We Know?

There is no shortage of hyperbole when politicians of all stripes describe the nature and effects of video games. Republican presidential candidate Mitt Romney proclaimed, "Pornography and violence poison our music and movies and TV and video games.


Eugenio M. Rothe, MD

Latest:

Supportive Psychotherapy in Everyday Clinical Practice: It’s Like Riding a Bicycle

Supportive psychotherapy can serve as the first bridge out of social isolation and marginalization and addresses personality issues, such as deficits in character structure and defense mechanisms.


Eva C. Ihle, MD, PhD

Latest:

What to Do When Being There Means Being Vulnerable

In the early days of the pandemic, there was debate about whether clinical services for patients with psychiatric illness were “essential.” The evolution of psychiatric consultation-liaison services to medically hospitalized patients was no less complex.


Eva Szigethy, MD, PhD

Latest:

6 Strategies to Prevent Physician Burnout

Once a health care professional has reached a chronic stage of burnout, lives may be at stake. But prevention and treatment are possible.


Eve Caligor, MD

Latest:

Psychodynamic Treatments

Mentalization-based treatment (MBT) and transference-focused psychotherapy (TFP) are relatively complex and specialized treatments for the treatment of borderline personality disorder.


Evelina W. Sterling, PhD, MPH

Latest:

Chronic Disease Self-Management Programs in Psychiatry

Through patient self-management, mental health clinicians can transfer the focus from managing symptoms to allowing patients to live well in the context of their mental illness and medical comorbidities.


Evelyn Attia, MD

Latest:

An Overview of Eating Disorders

Eating disorders, such as anorexia nervosa, bulimia nervosa, and binge eating disorder remain a challenge, but research continues and more is learned every day. Experts discuss symptoms, diagnostic criteria, and medical complications of eating disorders, as well as implications for treatment.


Evian Gordon, PhD

Latest:

Gender Differences, Gamma Phase Synchrony and Schizophrenia

The authors discuss gender differences found in patients with schizophrenia. Their group is the first to explore the possibility that gender differences in schizophrenia are mediated by differences in integrative network activity, reflected in a synchronous phase of high frequency (40 Hz) gamma activity.


Ewald Horwath, MD

Latest:

Psychiatric Manifestations of HIV Infection and AIDS

Patients with HIV infection are at risk of developing psychiatric symptoms and disorders similar to those seen in the general population. What unique biological, psychological and environmental factors are involved in treating this population?


Eyal Shemesh, MD

Latest:

Posttraumatic Stress in Medically Ill Patients

A major physical illness or procedure, such as a myocardial infarction (MI), a transplant operation, or a life-threatening attack of asthma, can be emotionally traumatic,1,2 but the study of posttraumatic reactions in the medically ill is relatively new. Only in the past 2 decades or so it has been recognized that, in fact, medical illness and its treatment can be traumatic, and only since the publication of DSM-IV in 1994 has medical illness been included as a potentially traumatic event that may lead to the development of posttraumatic symptoms.


Ezra S. Susser, MD

Latest:

Prenatal Risk Factors in Schizophrenia

Significant research developments in the etiopathogenesis of schizophrenia have occurred during the past several years. One such advance is the "neurodevelopmental" hypothesis that events during early brain development, especially the prenatal and perinatal periods, may play an important causal role in at least some, and perhaps many, cases of schizophrenia.


F. Andrew Kozel, MD, MSCR

Latest:

Neuroimaging of Mood Disorders

Help in Clinical Decision Making


F. Theodore Reid, Jr, MD

Latest:

Overcoming Resistant Personality Disorders: A Personalized Psychotherapy Approach

Overcoming Resistant Personality Disorders is a provocative and well-reasoned, yet frustrating volume. In it, the authors challenge various authorities on the subject; for example, they criticize the DSM for its failure to "officially endorse an underlying set of principles that would interrelate and differentiate the categories in terms of their deeper principles" and for its current Axis II categories.


Fabian M. Saleh, MD

Latest:

Psychopathy: Insights for General Practice

While incarceration is the definitive “treatment” for some, psychopathy exists on a spectrum like any other mental disorder; more recent research suggests the condition is capable of responding to treatment.

© 2024 MJH Life Sciences

All rights reserved.